The Research and Development team at Oric Pharmaceuticals is responsible for discovering and developing innovative oncology treatments targeting mechanisms of resistance. They work on advancing the company's pipeline, including the lead asset ORIC-101, by conducting preclinical and clinical research, managing regulatory affairs, developing formulations and drug delivery systems, and utilizing data science and bioinformatics to support their findings.
Alex Pankov
Associate Director, Head Of Bi...
Ali Reza Mohebbi
Senior Manager, CMC
Anthony Romero
Sr. Director, Head Of Chemistr...
Archana Akalkotkar
Sr Manager Analytical Chemistr...
Gina Andreatta
Research Associate II - In Viv...
Htlcm Frank L Duong ...
Sr. Research Associate, In Viv...
Jian Wang
Director, Data Sciences
Lori Friedman
Chief Scientific Officer
Sandy Koppenol
Director Of Formulation And Dr...
Siyu Liu
Research Associate
View all